Inhibition of IL-6 for the treatment of inflammatory diseases.

Curr Opin Pharmacol

Laboratory of Immune Regulation, Graduate School of Frontier Biosciences, Osaka University, 1-3 Yamada-oka, Suita-City, Osaka, 565-0871, Japan.

Published: August 2004

Interleukin-6 (IL-6) is a pleiotropic cytokine with various biological activities. Deregulated overproduction of IL-6 has been found to play pathological roles in chronic inflammatory diseases such as rheumatoid arthritis, Castleman's disease, juvenile idiopathic arthritis and Crohn's disease. Humanized anti-IL-6 receptor antibody has been developed as a therapeutic agent for these diseases, and therapeutic benefits have been revealed in clinical studies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coph.2004.03.005DOI Listing

Publication Analysis

Top Keywords

inflammatory diseases
8
inhibition il-6
4
il-6 treatment
4
treatment inflammatory
4
diseases interleukin-6
4
interleukin-6 il-6
4
il-6 pleiotropic
4
pleiotropic cytokine
4
cytokine biological
4
biological activities
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!